Enhancing predictive biomarkers in limited cutaneous systemic sclerosis: the role of type I interferon score and sex considerations: comment on the article by Di Donato et al

Documents similaires

• Circulating interferon alpha protein measured with digital enzyme‐linked immunosorbent assay as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the article from Di Donato et al
  par: Carine Schmidt, et autres
  Publié: (2025)
• Epitope spreading and systemic sclerosis: comment on the article by Kotani et al
  par: Ranjeet Singh Mahla
  Publié: (2025)
• Enhancing knee osteoarthritis prediction: comment on the article by Li et al
  par: Qin Guo, et autres
  Publié: (2025)
• Methodological considerations for “Proinflammatory dietary pattern and the risk of female gout”: comment on the article by Rai et al
  par: Fusen Chen, et autres
  Publié: (2025)
• Limitations in targeting Modic type 1 changes with systemic TNF inhibition: comment on the article by Gjefsen et al
  par: Qu Zheng, et autres
  Publié: (2025)